跳至主要内容
临床试验/NCT04298619
NCT04298619已完成不适用

Impact on Survival of Early Detection of Recurrence in the Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

Federico II University0 个研究点目标入组 123 人开始时间: 2001年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
123
主要终点
Event Free Survival (EFS)

研究概览

简要总结

Cohort study enrolled high-risk Hodgkin Lymphoma patients in first relapse after induction therapy followed after remission either with a systemic imaging-based surveillance (Imaging cohort) or with standard clinical-based surveillance (standard cohort).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • High risk Hodgkin Lymphoma
  • achievement of complete response to first line therapy

排除标准

  • comorbidities that could impair participation in follow-up procedures

结局指标

主要结局

Event Free Survival (EFS)

时间窗: Time period from the first relapse after induction therapy to the date of an event (refractoriness, relapse, or death) or the last follow-up visit after autologous stem cell transplantation (ASCT), up to 2 years

Events: * refractoriness * relapse * death

次要结局

  • Response rate(After salvage therapy and autologous stem cell transplantation (ASCT), up to 2 years)
  • EFS for clinically silent relapses(Time period from the first relapse after induction therapy to the date of an event (refractoriness, relapse, or death) or the last follow-up visit after autologous stem cell transplantation (ASCT), up to 2 years)

研究者

发起方
Federico II University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marco Picardi

Professor

Federico II University

相似试验